Connect with us


Missouri Bill Would Add Psychedelics to State’s “Right to Try” Law



A Missouri lawmaker proposed expanding the state’s Right to Try law to include various psychedelic substances, including LSD, MDMA, mescaline, DMT and mushrooms.

Missouri’s Right to Try Law, enacted in 2014, allows terminally ill patients access to a number of experimental drugs, devices and procedures that are not approved by the US Food and Drug Administration. The proposed substances would only be available after going through all other treatment options. The new bill would also allow drug manufacturers to legally produce the substances under state law and physicians and pharmacies can lawfully distribute them.

Current state law specifically does not allow the use of Schedule I controlled substances. Missouri does however allow the use of medical cannabis, a Schedule I substance, with sales beginning near the end of last year. The new bill would remove that provision from the law.

“My proposal protects the liberty interests of Missourians who believe these drugs offer valuable options in the treatment of numerous conditions, and, importantly, aligns Missouri law with federal law with respect to investigational drug access,” Representative Michael Davis said.

The proposal would also reduce existing criminal penalties for possession of the psychedelic substances. Current law says possession of any amount of the substances is a class D felony, resulting in a sentence of up to seven years in prison. The proposal would change possession of up to 10 grams to a class D misdemeanor, which carries a maximum $500 fine. Possession of 10 to 35 grams would become a class A misdemeanor, which would result in a maximum fine of $2,000 and up to a year in prison.A similar measure to expand the Right to Try law was introduced in Iowa. Representative Jeff Shipley, who introduced the bill, also recently introduced legislation that would remove psilocybin from Iowa’s banned substances list.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *